Clinical Trials Directory

Trials / Completed

CompletedNCT02864966

A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects

A 24 Hour Occlusive Single Patch Test to Assess, Under Dermatological Control, the Acute Cutaneous Tolerance of Pre Lubricated Kiss Condom on a Panel of Healthy Adult Subjects

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Reckitt Benckiser Healthcare (UK) Limited · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This is a 24 hour patch test to determine the acute tolerance of 3 variants of condom on a panel of healthy adult subjects. The patches will be affixed to the back and remain under occlusion for 24 hours. They will then be assessed at 30 minutes and 24 hours post patch removal.

Detailed description

Three test products (plus positive and negative control) will be applied to the back using occlusive tape and will remain on the skin for 24 hours. The patches will be removed after 24 hours and assessed as 30 minutes post patch removal and again at 24 hours post patch removal. Each test site will be scored for erythema and oedema by a dermatologist. The primary endpoint for this Clinical Investigation is the irritation of the test products according to the Cutaneous Irritancy Index value. The test products success criteria is to be graded as 'non-irritant' and this should be confirmed by the study dermatologist.

Conditions

Interventions

TypeNameDescription
DEVICECondomThis study involves testing a condom, however the device will not be used as intended. The device will be destroyed to make the test patches required for this safety study.

Timeline

Start date
2016-05-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2016-08-12
Last updated
2016-09-09

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT02864966. Inclusion in this directory is not an endorsement.